Amol Mehta, MD
@AmolMehtaMD
Followers
344
Following
1K
Media
14
Statuses
244
Neuroendovascular Surgery Fellow @MountSinai former @Columbianeuron Interested in: Neurointervention, Stroke, Public Health, Jazz Saxophone
Joined September 2012
The 36th Sidney A Hollin, MD, Memorial Lecture was a success! #HollinLecture guest speaker Dr @jmascite (@UTHealthSA + @MountSinaiNeuro residency & #NeuroendovascularSurgery fellow alum) presented “Open #VascularNeurosurgery Is Not Dead Yet!” Thanks for sharing your expertise!🧠
2
4
15
Positive 12M results in bailout PTA/Stenting in 🇨🇳REBOOT RCT. https://t.co/buTxIggXWS PTA/Stenting improved 1-year mRS (gOR, 1.34). Fewer stroke recurrences (4% vs. 13%). @_AdnanSiddiqui @Acandisgmbh @STateshimaMD @Cure4Stroke
4
18
39
Early recurrence in medically treated patients with symptomatic ICAS is driven by impaired distal perfusion. Happy to share that the BIORISK ICAS study was presented at WSC and published in stroke. I am grateful for our collaborators from across the world. https://t.co/wAnHhGvUPp
2
32
90
Dr. Rahmani and others supporting endovascular venous thrombectomy. Rare cause of stroke, but with new devices, intervention may be the best option https://t.co/0Y449hcjLP
jnis.bmj.com
Cerebral venous sinus thrombosis (CVST) is a relatively rare type of stroke (0.5% of all strokes), with a prevalence of 5 per million people.1 It predominantly affects younger age groups, particula...
0
3
10
Editorial: The ATIS-NVAF trial shows adding antiplatelet therapy to OAC in stroke patients with AF and atherosclerotic disease increases major bleeding without significant reduction in ischemic events. https://t.co/4qDFaL6m5H
0
44
132
Yes. I’d change my practice based on this even though it’s a subgroup analysis
#STROKE: In a secondary analysis of ARCADIA, randomization to apixaban was associated with a lower risk of recurrent ischemic stroke than aspirin in patients with left ventricular systolic dysfunction. @MitchElkind @hoomankamel @ShadiYaghi2 #AHAJournals
https://t.co/3fntF9AlNV
0
0
2
Thrombectomy is superior to Best Medical Therapy for LVO stroke w/ penumbra presenting Beyond 24 Hours: A Systematic Review and Meta-Analysis https://t.co/y6lXcIwky1
ahajournals.org
BACKGROUND: The benefit of endovascular thrombectomy (EVT) beyond 24 hours from last known well in acute ischemic stroke remains uncertain. Although some slow progressors may retain salvageable...
1
28
60
EVT is a technically feasible approach that may also produce positive clinical outcomes in the treatment of symptomatic intradural CTOs, according to Re-CHILL study findings disclosed at the 2025 @esmintsociety congress by @PCimflova
https://t.co/pnRrIXvwRs
neuronewsinternational.com
Endovascular therapy (EVT) appears to be a technically feasible approach that may also produce positive clinical outcomes in the treatment of symptomatic intradural chronic total occlusions (CTOs),...
0
1
6
We are excited to announce that the primary results of the pioneering GRASSROOT INDIA Trial will be presented for the first time at the World Stroke Congress 2025 in Barcelona, Spain on October 23rd #GRASSROOT #GravityMedTech #Supernova #IndiaApproval #WSC2025 #onecountryatatime
0
5
16
#STROKE: This special report by @AmolMehtaMD et al. critically appraises recent literature on endovascular thrombectomy for medium vessel occlusion stroke and offers consideration for practice. #AHAJournals
https://t.co/BKDnRMukbo
3
42
162
#STROKE: In a case series of patients with acute stroke, photon-counting CT was able to accurately distinguish contrast extravasation from intracranial hemorrhage. #AHAJournals
https://t.co/T9lcNBEHnu
0
19
67
Consensus Statement on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma Treatment https://t.co/PmmAomxaXR
@StrokeAHA_ASA @SVINJournal @StrokeAHA_ASA
1
33
106
In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. https://t.co/yWAe7yPCSN
0
27
62
0
0
1
The GRASSROOT India Trial results will be presented for the 1st time at the WSC 2025 in Barcelona. This landmark study served as the foundation for the approval of the Supernova stent retriever in India-a pivotal step in our mission to expand access to high-quality stroke care.
1
1
4
Aneurysm wall enhancement on MRI, particularly circumferential AWE, may be used to predict the risk of instability in unruptured intracranial aneurysms over a four-year period. https://t.co/3QiuYDbYEa
0
26
79
Did you know that thrombectomy NEVER WORKED until suddenly it did in Oct 2015? 😜 Of course it did. It’s all about pt selection. I agree with these guys re: MeVO. Should We Stop Endovascular Treatment of M2 Occlusions?: A Critical Look
ahajournals.org
Medium vessel occlusions represent a substantial proportion of patients with acute ischemic stroke. Recently presented randomized controlled trials, ESCAPE-MeVO (Endovascular Treatment to Improve...
2
16
56
Thrilled to publish this piece in @StrokeAHA_ASA alongside several of my mentors to hopefully clarify current dilemmas on the treatment of M2 occlusions, and to encourage the community to treat proximal/dominant M2s in the post MEVO trial era.
Proximal and/or dominant M2=TREAT‼️Jury out on other M2’s but likely treat if disabling! Check out more here! @AmolMehtaMD @JMoccoMD @eytanraz @ShashvatDesai @NguyenThanhMD @SunilAShethMD @AshuPJadhav
1
22
80
Being a senior fellow is sweett. TICI3 1 pass, 7 min groin puncture to recanalization! With Zoom 7X and CDAT! @ImpCare_Vasc under the auspices of @MajidiShahram NIHSS 7->1 and no infarct on MRI
0
1
7
HOB flat please Optimal Head-of-Bed Positioning Before Thrombectomy in Stroke
jamanetwork.com
This randomized clinical trial investigates if use of a 0° head position is superior to a 30° head position for maintaining clinical stability in individuals with large vessel occlusion stroke who...
0
0
8